The expansion will add 9,000 square feet to its Massachusetts facility, expanding development and production capabilities.

Will support spray drying and unit operations including granulation, encapsulation, compression and coating for oral dosage ...

Together, they will find partners for the development of the ‘RSH Olfactory Delivery Device,’ a dual nostril intranasal platform used for precisely targeting specific regions of the nasal cavity.

To install a new sterile filling line, significantly increasing its production capacity for sterile vials or freeze-drying.

LOTTE BIOLOGICS has signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma, a biopharmaceutical company developing first-in-class, PD1/VEGFR2 dual pathway antibodies to ...

AI-GO aims to improve quality, efficiency, and competitiveness in the pharmaceutical and manufacturing sectors.

Aims to advance next-gen immunotherapies targeting the dark proteome.